Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wound healing modulation after glaucoma surgery.

M F Cordeiro1, D Siriwardena, L Chang

  • 1Department of Pathology, Moorfields Eye Hospital, London, UK.

Current Opinion in Ophthalmology
|June 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcriptome-wide analysis of N6-methyladenosine uncovers its regulatory role in gene expression in the lepidopteran Bombyx mori.

Insect molecular biology·2019
Same author

miR-375 inhibits the proliferation and invasion of glioblastoma by regulating Wnt5a.

Neoplasma·2019
Same author

[Analysis of clinical factors on early pregnancy loss during in vitro fertilization-embryo transfer treatment and natural pregnancy].

Zhonghua fu chan ke za zhi·2018
Same author

Fulvestrant inhibits the glycolysis of prolactinoma GH3 cells by downregulating IRE1/XBP1 signaling pathway.

European review for medical and pharmacological sciences·2018
Same author

[A case report: Ramsay Hunt syndrome with throat as starting place merger ipsilateral cranial nerver involvement].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2018
Same author

[Effects of tetrandrine on proliferation and activation of cardiac fibroblasts].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2018
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

New therapies, including molecular-based treatments like monoclonal antibodies, show promise for modulating scarring after glaucoma surgery. These advanced approaches offer safer and more targeted interventions for improved surgical outcomes.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Cell Biology

Background:

  • Wound healing and scarring significantly impact surgical outcomes, particularly after glaucoma surgery.
  • Molecular and cell biology advancements are enhancing our understanding of the scarring process.

Purpose of the Study:

  • To review current and potential therapies for modulating the scarring response after glaucoma surgery.
  • To highlight novel molecular-based strategies for improving surgical results.

Main Methods:

  • Review of existing literature on wound healing and surgical modification.
  • Analysis of antimetabolite regimens and their efficacy.
  • Exploration of molecular-based therapies, including monoclonal antibodies.

Related Experiment Videos

Main Results:

  • Refinement of antimetabolite regimens can improve outcomes in select patients.
  • Molecular-based therapies targeting specific scarring molecules are highly promising.
  • These novel strategies offer potential for safer, more focused, and adjustable treatments.

Conclusions:

  • Advanced molecular therapies represent a significant future direction for managing glaucoma surgery scarring.
  • Targeted antibody treatments hold potential for safer and more effective clinical applications.
  • Continued research in molecular and cell biology is crucial for optimizing surgical interventions.